A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Carcinoma
Interventions: DRUG: Tamoxifen|DRUG: Fulvestrant|DRUG: Fulvestrant
Sponsor: University of Southern California
Collaborators: AstraZeneca